Ronald Muhlenkamp recent buys & sells (2021 Q4)
Muhlenkamp & Co
Muhlenkamp & Co Portfolio Changes
Purchase & sale details
- Portfolio value:
- $286.94M (+$26M)
- Previous value:
- $260.44M
- # of changes:
- 31
- New positions:
- 3
- Reported for:
- 31 Dec 2021 (Q4)
- Latest filing date:
- 29 Mar 2022
Muhlenkamp & Co has disclosed a total of 31 changes to the portfolio in the (2021 Q4) SEC report(s): increased the number of shares of 6, bought 3 totally new and decreased the number of shares of 22 position(s).
What stocks did Ronald Muhlenkamp buy in 2021 Q4?
During 2021 Q4 Ronald Muhlenkamp has bought 9 securities out of which top 5 purchases (by % change to portfolio) were (MCHP) Microchip Technology Inc (added shares +252.38%), (EQT) EQT Corp (new buy), (BMY) Bristol-Myers Squibb Company (added shares +0.45%), (NMIH) NMI Holdings Inc (added shares +0.25%) and (LMT) Lockheed Martin Corp (added shares +0.56%).
In the 2021 Q4 report(s) the following changes have been made to the top investments: (WCC) WESCO International Inc (reduced shares -0.29%), (MCK) McKesson Corp (reduced shares -0.07%), (MSFT) Microsoft Corp (reduced shares -0.06%), (MCHP) Microchip Technology Inc (added shares +252.38%) and (AVGO) Broadcom Inc (reduced shares -10.33%).
31 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
EQT Corp
|
new
|
+444,283
|
444,283
|
+3.38%
|
$21.81
|
+148.53%($54.20)
|
3.38%
|
2021 Q4
|
~0.25 years
|
|
|
|
Invesco BuyBack Achievers ETF
|
new
|
+5,699
|
5,699
|
+0.19%
|
$96.51
|
+54.32%($148.93)
|
0.19%
|
2021 Q4
|
~0.25 years
|
|
|
|
LOYALTY VENTURES INC
|
new
|
+49,222
|
49,222
|
+0.52%
|
$30.07
|
|
0.52%
|
2021 Q4
|
~0.25 years
|
|
|
|
Microchip Technology Inc
|
+252.38%
|
+119,766.5
|
167,222
|
+3.63%
|
$87.06
|
-14.24%($74.66)
|
5.07%
|
2017 Q1
|
~4.50 years
|
|
|
|
Royal Gold Inc
|
+69.75%
|
+16,984
|
41,334
|
+0.62%
|
$105.22
|
+124.60%($236.32)
|
1.52%
|
2020 Q4
|
~1.25 years
|
|
|
|
Franco-Nevada Corp
|
+67.07%
|
+13,986
|
34,839
|
+0.67%
|
$138.29
|
+74.90%($241.88)
|
1.68%
|
2020 Q4
|
~1.25 years
|
|
|
|
Lockheed Martin Corp
|
+0.56%
|
+108
|
19,427
|
+0.01%
|
$355.43
|
+54.25%($548.27)
|
2.41%
|
2019 Q3
|
~2.25 years
|
|
|
|
Bristol-Myers Squibb Company
|
+0.45%
|
+568
|
125,987
|
+0.01%
|
$62.35
|
-2.72%($60.65)
|
2.74%
|
2019 Q4
|
~2.00 years
|
|
|
|
NMI Holdings Inc
|
+0.25%
|
+809
|
330,870
|
+0.01%
|
$21.85
|
+85.43%($40.52)
|
2.52%
|
2020 Q2
|
~1.75 years
|
|
|
|
Berkshire Hathaway Inc
|
-0.01%
|
-4
|
36,971
|
-0%
|
$298.99
|
+77.02%($529.26)
|
3.85%
|
2019 Q3
|
~2.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".